Patents by Inventor Jonathan Sleeman

Jonathan Sleeman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CHEMICAL INHIBITORS OF ID PROTEINS FOR THE TREATMENT OF CANCER AND OTHER DISEASES
    Publication number: 20220259172
    Abstract: The present invention relates to compounds that inhibit expression of Id1 and/or Id3, as well as uses thereof in the treatment of cancer and other diseases and conditions associated with Id1 and/or Id3 expression.
    Type: Application
    Filed: June 10, 2020
    Publication date: August 18, 2022
    Inventors: Jonathan SLEEMAN, Georg SEDLMEIER, Nicole JUNG, Stefan BRÄSE, Simone GRÄSSLE
  • Agent for identifying and treating metastasizing tumors
    Patent number: 6391301
    Abstract: The present invention relates to a novel composition for identifying and suppressing the growth of tumor cells, which comprises antibodies which react with proteins having N-glycosidically bonded saccharides.
    Type: Grant
    Filed: August 16, 1999
    Date of Patent: May 21, 2002
    Assignee: Forschungszentrum Karlsruhe GmbH
    Inventors: Jonathan Sleeman, Helmut Ponta, Peter Herrlich, Kim Untae